RE: India Update - Anyone can now get a test8 Jul 2020 12:02
@Madhav
I am in a similar position as you, i do believe that if the approvals come the SP will rise. My own guess is around 20% on FDA. But please dont take my word for it. Its just a guess. Others believe a 10% raise is more appropriate.
There is no such thing as deramping, nothing to be afraid of, speak your mind, ask anything you like. Just remember the names of the rampers, only a few left now. Any replies from them, treat them with the suspicion they deserve.
Back to your question, i believe two things have happened here.
The covid bubble was massive, and at the time we bought in, everything was 100% on any news. The downside was we bought in at a price which is at odds with the 'current' value. Will we get to 300p - not any time soon is my opinion, ask others and see what they think, just not the rampers.
The second issue is maybe the company or the rampers on here led people like us to believe GDR were ahead of the game, except there weren't. The fact that its taken them nearly 2 months following CE and we still dont have approvals probably shows that GDR were shortsighted, naive, hedged all their bets for the NHS etc etc heck they only tried to recruit someone two weeks ago on a 3 month contract, whilst all their competitors are recruiting senior positions full time. It could also be GDR just plain didnt have a fully market ready test package or the test results which work on an open source system didnt work like expected and this caused bigger issues than DB let on (DB admitted to this). I am not going to say us investors misinterpreted the company position in the market place because NCYT has made sales, ODX have made a small 100k sale. Globally lots of Covid companies are making sales.